CMV-Associated Thrombosis in a Kidney Transplant Recipient

被引：0
|
作者：
Hsu, Young C. [1 ,2 ]
Wang, Lin [1 ,2 ]
Thanh Cao [1 ,2 ]
Sharma, Neeraj [1 ,2 ]
机构：
[1] Univ Southern Calif, Los Angeles, CA 90007 USA
[2] USC, Keck Hosp, Los Angeles, CA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PUB295
引用
收藏
页码：847 / 847
页数：1
相关论文
共 50 条
  • [41] Characterization of CMV-associated adaptive NK cells in rhesus macaque
    Hasan, M. Z.
    Petersen, B.
    Dressel, R.
    Walter, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 112 - 112
  • [42] Mutated podocin manifesting as CMV-associated congenital nephrotic syndrome
    Yaacov Frishberg
    Choni Rinat
    Sofia Feinstein
    Rachel Becker-Cohen
    Orli Megged
    Yechiel Schlesinger
    Pediatric Nephrology, 2003, 18 : 273 - 275
  • [43] Clinical Features of CMV-Associated Anterior Uveitis in Immunocompetent Patients
    Alqahtani, A. S.
    Angi, M.
    Rozenberg, F.
    Touitou, V.
    Terrada, C.
    Cassoux, N.
    Fardeau, C.
    LeHoang, P.
    Bodaghi, B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [44] Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient
    Byrns, J.
    Katz-Greenberg, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 775 - 775
  • [45] Mutated podocin manifesting as CMV-associated congenital nephrotic syndrome
    Frishberg, Y
    Rinat, C
    Feinstein, S
    Becker-Cohen, R
    Megged, O
    Schlesinger, Y
    PEDIATRIC NEPHROLOGY, 2003, 18 (03) : 273 - 275
  • [46] Age matters: older age as a risk factor for CMV reactivation in the CMV serostatus-positive kidney transplant recipient
    Hemmersbach-Miller, Marion
    Alexander, Barbara D.
    Pieper, Carl F.
    Schmader, Kenneth E.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2020, 39 (03) : 455 - 463
  • [47] Impacts of Recipient/Donor CMV Status and CMV Prophylaxis on Kidney Transplant Outcomes, an Analysis Using OPTN/UNOS Database
    Kuo, Hung-Tien
    Sampaio, Marcelo
    Ye, Xiaoyi
    Reddy, Pavani
    Poommipanit, Neda
    Bunnapradist, Suphamai
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 327 - 327
  • [48] CMV-ASSOCIATED LYMPHADENOPATHY IN THE NORMAL HOST - A HISTOPATHOLOGIC AND IMMUNOPHENOTYPIC DESCRIPTION
    VAGO, JF
    TITMAN, WE
    SWERDLOW, SH
    LABORATORY INVESTIGATION, 1989, 60 (01) : A100 - A100
  • [49] SHOULD ISOLATED CALF VEIN THROMBOSIS BE TREATED WITH ANTICOAGULANT IN KIDNEY TRANSPLANT RECIPIENT?
    Kim, Jiil
    Moon, InSung
    Kim, Mi-hyeong
    TRANSPLANT INTERNATIONAL, 2019, 32 : 190 - 190
  • [50] CYTOMEGALOVIRUS (CMV) TITERS IN KIDNEY-TRANSPLANT DONOR AND RECIPIENT - INFLUENCE OF CYCLOSPORIN-A (CYA)
    HARRIS, KR
    SAEED, A
    GEOGHEGAN, TA
    DIGARD, N
    LEE, HA
    SLAPAK, M
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 2199 - 2199
12345